Cargando…
SARS-CoV-2 origin, myths and diagnostic technology developments
BACKGROUND: After the first case of COVID-19 being announced in China in December 2019, various diagnostic technologies have been developed at unprecedented pace with the aim of providing a basis for accurate clinical intervention. However, some assays including CRISPR-based diagnostics and loop-med...
Autores principales: | Wambani, Josephine, Okoth, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893981/ https://www.ncbi.nlm.nih.gov/pubmed/37521834 http://dx.doi.org/10.1186/s43042-022-00255-3 |
Ejemplares similares
-
Scope of SARS-CoV-2 variants, mutations, and vaccine technologies
por: Wambani, Josephine, et al.
Publicado: (2022) -
Impact of Malaria Diagnostic Technologies on the Disease Burden in the Sub-Saharan Africa
por: Wambani, Josephine, et al.
Publicado: (2022) -
SARS-CoV-2 and the myths about vaccination()
por: Travezaño-Cabrera, Aaron, et al.
Publicado: (2021) -
Are smokers protected against SARS-CoV-2 infection (COVID-19)? The origins of the myth
por: van Westen-Lagerweij, Naomi A., et al.
Publicado: (2021) -
Origin and evolution of SARS-CoV-2
por: Pagani, Isabel, et al.
Publicado: (2023)